← Back to Search

Behavioral Intervention

Pharm-SAVES for Suicide

N/A
Waitlist Available
Led By Jill E Lavigne, PhD
Research Sponsored by University of North Carolina, Chapel Hill
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1-month follow-up
Awards & highlights

Study Summary

This trial will test if pharmacy staff can be trained to communicate better about suicide prevention with customers.

Eligible Conditions
  • Suicide

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1-month follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1-month follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in proportion of participants who ask about suicide.
Secondary outcome measures
Change in mean suicide prevention preparedness score from baseline to 1-month follow-up.
Change in mean suicide prevention preparedness score from baseline to immediate post-intervention.
Change in mean suicide prevention self-efficacy score from baseline to 1-month follow-up
+4 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Interactive video caseExperimental Treatment2 Interventions
An approximately 30-minute self-guided online suicide prevention gatekeeper skills training module, plus two approximately 5-minute interactive video cases in which participants are asked to respond to patients who exhibit suicidal warning signs.
Group II: Pharm-SAVESActive Control1 Intervention
This is an approximately 30-minute self-guided online module that covers basic information about suicide prevention gatekeeper skills training that is relevant to community pharmacists.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Pharm-SAVES
2022
N/A
~120
Interactive video cases
2022
N/A
~120

Find a Location

Who is running the clinical trial?

University of North Carolina, Chapel HillLead Sponsor
1,498 Previous Clinical Trials
4,176,093 Total Patients Enrolled
3 Trials studying Suicide
1,726 Patients Enrolled for Suicide
American Foundation for Suicide PreventionOTHER
32 Previous Clinical Trials
9,610 Total Patients Enrolled
20 Trials studying Suicide
8,213 Patients Enrolled for Suicide
US Department of Veterans AffairsFED
867 Previous Clinical Trials
487,731 Total Patients Enrolled
8 Trials studying Suicide
1,718 Patients Enrolled for Suicide

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does the eligibility criteria for this trial extend to individuals over forty years of age?

"As per the admission criteria, this medical trial is open to individuals aged between 18 and 99. Furthermore, there are 58 trials for minors (under 18) and 118 studies specifically tailored towards those over 65 years old."

Answered by AI

Is enrollment in this medical trial still an option?

"Data found on clinicaltrials.gov confirms that this research project is still open to patient recruitment, with the initial post date of December 9th 2021 and last update occurring on December 1st 2022."

Answered by AI

To what extent is the capacity of this experiment being tested?

"Affirmative, the clinicaltrials.gov website reveals that enrollment for this trial is in progress. This study was initially listed on December 9th 2021 and most recently updated on December 1st 2022; 150 people are needed to take part at one site only."

Answered by AI

Am I eligible to take part in this research study?

"The aim of this clinical trial is to enrol 150 sufferers from suicide, aged 18 and above, who have a command of the English language as well as being employed in either pharmacy or pharmacy technician."

Answered by AI
~41 spots leftby Mar 2025